RecruitingPhase 1NCT07118319
The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis
Studying Juvenile amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.
- Intervention
- Human Allogeneic Induced Pluripotent Stem Cells (iPSCs) -Derived Motor Neuron Progenitor Cells (XS228CN)(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2025 – 2028
Study locations (1)
- Peking University Third Hospital, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07118319 on ClinicalTrials.govOther trials for Juvenile amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07175935Amyotrophic Lateral Sclerosis Registry in ThailandChulalongkorn University
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06392126Personalized Antisense Oligonucleotide Therapy for A Single Participant With CHCHD10 ALSn-Lorem Foundation
- RECRUITINGNCT06354244Electroacupuncture of Different Treatment Frequency in Chronic Urinary Retention Caused by Lower Motor Neuron LesionsGuang'anmen Hospital of China Academy of Chinese Medical Sciences
- RECRUITINGNCT05491577Factors Associated With an Evolution in the Quality of Life of Diabetic Patients With Chronic, Wound-free Charcot FootCentre Hospitalier Universitaire de Nīmes
- ACTIVE NOT RECRUITINGPHASE1NCT05633459A Study Evaluating the Safety and Tolerability of QRL-201 in ALSQurAlis Corporation
- RECRUITINGNANCT04868994Magnetic Imaging for Diagnostic of Amyotrophic Lateral SclerosisUniversity Hospital, Toulouse
- ACTIVE NOT RECRUITINGNANCT03766321Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis PatientsAzienda Ospedaliero-Universitaria di Modena
- RECRUITINGNCT02869048Amyotrophic Lateral Sclerosis and the Innate Immune SystemRigshospitalet, Denmark